Diamond Biofund Announces Changes in Investment Holdings, Fair Value, Net Asset Value Per Share, and Cash Balance
Key facts
- Diamond Biofund Announces Changes in Investment Holdings, Fair Value, Net Asset Value Per Share, and Cash Balance
- 鑽石生技投資公告115年3月份投資標的股數與公允價值變動，以及每股淨值與現金餘額。
- Source: PR Times
- Date: April 9, 2026
Direct answer
鑽石生技投資公告115年3月份投資標的股數與公允價值變動，以及每股淨值與現金餘額。
- Citation
- Diamond Biofund Announces Changes in Investment Holdings, Fair Value, Net Asset Value Per Share, and Cash Balance (April 9, 2026), PR Times
- Source
- PR Times
- Date
- April 9, 2026
鑽石生技投資公告115年3月份投資標的股數與公允價值變動，以及每股淨值與現金餘額。
📋 Article Processing Timeline
- 📰 Published: April 9, 2026 at 09:00
- 🔍 Collected: April 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 17, 2026 at 01:06 (881h 6m after Collected)
Diamond Biofund Inc. announced its monthly report for March. The holdings of most invested companies remained unchanged, but the total fair value decreased by NT$84,898 thousand due to stock price fluctuations, with StemCyte and Sinphar suffering the most significant drops. As of the end of March, the net asset value per share was NT$10.40, and the cash and cash equivalents balance stood at NT$2,733,439 thousand. The company noted that investments in biotech stocks are highly volatile due to R&D outcomes, which may result in negative operating revenue when fair value declines.
FAQ
What are the key facts in this article?
鑽石生技投資公告115年3月份投資標的股數與公允價值變動，以及每股淨值與現金餘額。
What is the direct answer?
鑽石生技投資公告115年3月份投資標的股數與公允價值變動，以及每股淨值與現金餘額。
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-6901-2026-04-09-b8438dd4 | April 9, 2026